Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma

被引：0
|
作者：
Gurnell, M. [1 ]
Domingo, C. [2 ,3 ]
Rabe, K. F. [4 ,5 ]
Menzies-Gow, A. [6 ]
Price, D. [7 ]
Brusselle, G. [8 ]
Wechsler, M. E. [9 ]
Xia, C. [10 ]
Pandit-Abid, N. [11 ]
Gall, R. [10 ]
Jacob-Nara, J. A. [11 ]
Rowe, P. J. [11 ]
Deniz, Y. [10 ]
Siddiqui, S. [10 ]
机构：
[1] Univ Cambridge, Wellcome MRC Inst Metab Sci, Cambridge, England
[2] Corp Sanitaria Parc Tauli, Sabadell, Spain
[3] Autonomous Univ Barcelona, Barcelona, Spain
[4] LungenClin Grosshansdorf, Airway Res Ctr North ARCN, Grosshansdorf, Germany
[5] German Ctr Lung Res DZL, Grosshansdorf, Germany
[6] Royal Brompton & Harefield Hosp, London, England
[7] Observat & Pragmat Res Inst, Midview City, Singapore
[8] Univ Ghent, Ghent, Belgium
[9] Natl Jewish Hlth, Denver, CO USA
[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[11] Sanofi, Bridgewater, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Asthma; Adults; Treatments;
D O I：
10.1183/13993003.congress-2022.3620
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3620
引用
收藏
页数：2
相关论文
共 50 条
  • [31] DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
    Maspero, Jorge
    Fitzgerald, Mark
    Pavord, Ian
    Wenzel, Sally
    Zhang, Bingzhi
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil
    Teper, Ariel
    CHEST, 2018, 154 (04) : 25A - 27A
  • [32] Dupilumab Reduces Oral Corticosteroid Use and Severe Exacerbations and Improves Lung Function in Patients With Oral Corticosteroid-Dependent Severe Asthma With and Without Comorbid Allergic Rhinitis in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Castro, Mario
    Maspero, Jorge
    Sher, Lawrence
    Rabe, Klaus
    Casale, Thomas
    Rice, Megan
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB173 - AB173
  • [33] DUPILUMAB REDUCES SEVERE ASTHMA EXACERBATION RATE AND IMPROVES LUNG FUNCTION REGARDLESS OF AGE AT ONSET OF ASTHMA: THE LIBERTY ASTHMA QUEST STUDY
    Castro, Mario
    Hanania, Nicola
    Quirce, Santiago
    Sher, Lawrence
    Maspero, Jorge
    Rice, Megan
    Djandji, Michel
    Ballard, Mark
    Rowe, Paul
    Deniz, Yamo
    Teper, Ariel
    CHEST, 2019, 156 (04) : 936A - 939A
  • [34] Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline
    Chanez, Pascal
    Garin, Margaret
    McDonald, Mirna
    Humbert, Marc
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [35] Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
    Maspero, Jorge F.
    Halpin, David M. G.
    Jackson, David
    Hanania, Nicola A.
    Castro, Mario
    Domingo, Christian
    Daizadeh, Nadia
    Djandji, Michel
    Rowe, Paul
    Deniz, Yamo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [36] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [37] DUPILUMAB REDUCED ORAL CORTICOSTEROID USE AND IMPROVED CLINICAL OUTCOMES REGARDLESS OF BASELINE OCS DOSE IN PATIENTS WITH UNCONTROLLED, SEVERE ASTHMA IN THE LIBERTY ASTHMA VENTURE STUDY
    Ribas, Cristian Domingo
    Maspero, Jorge
    Castro, Mario
    Hanania, Nicola
    Ford, Linda
    Halpin, David
    Jackson, David
    Daizadeh, Nadia
    Djandji, Michel
    Mitchell, Colin
    Crikelair, Nora
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Ortiz, Benjamin
    CHEST, 2021, 160 (04) : 1893A - 1897A
  • [38] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED PERSISTENT ASTHMA PATIENTS ACROSS BASELINE EXACERBATIONS
    Bernstein, J.
    Ford, L.
    Jayawardena, S.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S50 - S50
  • [39] MEPOLIZUMAB REDUCES EXACERBATIONS, OCS AND COST AMONG PATIENTS WITH SEVERE ASTHMA AND THE HIGHEST EXPENDITURES PRIOR TO TREATMENT
    Lugogo, Njira
    Bogart, Michael
    Corbridge, Tom
    Packnett, Elizabeth
    Wu, Juan
    Hahn, Beth
    CHEST, 2021, 160 (04) : 1811A - 1814A
  • [40] Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Pavord, I.
    Castro, M.
    Rabe, K. F.
    Hanania, N. A.
    Papi, A.
    FitzGerald, J. M.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345